Pet food manufacturer Mars Petcare is continuing to expand the veterinary leg of its business with the acquisition of European veterinary business AniCura for an undisclosed amount.
This follows Mars Petcare’s recent purchase of British veterinary group, Linnaeus.
AniCura was established in 2011 by Fidelio Capital and The Animal Hospital Foundation in Greater Stockholm as the first merger of companion animal hospitals in the Nordic region. Over the past seven years, the company has grown to employ more than 4 000 veterinary professionals at 200 animal hospitals and clinics across seven European countries.
AniCura’s existing management team, led by CEO Peter Dahlberg, will continue to lead and develop the business with a maintained focus on quality, innovation and entrepreneurship, nurturing a strong, unique culture and taking clinical decisions close to the patient and customer.
AniCura joins the manufacturer’s other veterinary companies including BluePearl, VCA, Banfield and Pet Partners and Linnaeus.
AniCura will continue to operate as a stand-alone business and brand. The acquisition is subject to regulatory approvals.
Peter Dahlberg, CEO AniCura, said: We have been on an amazing journey for the past seven years with strong support from our owners to build a European quality leader. To strengthen our capabilities and continue our rapid development, we look forward to join a family-owned business with deep industrial knowledge and a long-term dedication for pet health. We couldn’t be more excited about partnering with Mars to ensure we provide the best possible veterinary care now and in the future.”